Nicholson John
SVP &Chief Operating Officer | SVP &Chief Financial Officer
1 company
Nicholson John serves as a SVP &Chief Operating Officer at NKTR. Across recent SEC filings that breaks down to 0 buys and 24 sells. Those positions are worth an estimated $12.4M at current prices.
The biggest single holding is NKTR (~$12.4M) as SVP &Chief Operating Officer. The recent filings there lean toward selling, a net 839,484 shares.
Holdings by Company
NKTRAug 16, 2019
Current Shares162.8K
Value$12.45M
Net Activity-839,484
Bought: 0Sold: 839.5K
Transaction History
Showing 10 filings
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 16, 2019 | NKTR Nektar Therapeutics | SVP &Chief Operating Officer | Sell | 3,819 | $18.15 | $69,314.85 | -2.3% | |
| May 16, 2019 | NKTR Nektar Therapeutics | SVP &Chief Operating Officer | Sell | 4,077 | $31.37 | $127,895.49 | -2.4% | |
| Feb 19, 2019 | NKTR Nektar Therapeutics | SVP &Chief Operating Officer | Sell | 3,822 | $42.39 | $162,014.58 | -2.2% | |
| Jan 28, 2019 | NKTR Nektar Therapeutics | SVP &Chief Operating Officer | Sale+OE | 63,000 | $42.82 | $2,697,660.00 | -26.5% | |
| Nov 16, 2018 | NKTR Nektar Therapeutics | SVP &Chief Operating Officer | Sell | 5,982 | $38.25 | $228,811.50 | -3.3% | |
| May 16, 2018 | NKTR Nektar Therapeutics | SVP &Chief Operating Officer | Sell | 4,917 | $83.39 | $410,028.63 | -2.9% | |
| Mar 7, 2018 | NKTR Nektar Therapeutics | SVP &Chief Operating Officer | Sell | 220,144 | $99.27 | $21,854,264.80 | -33.6% | |
| Feb 16, 2018 | NKTR Nektar Therapeutics | SVP &Chief Operating Officer | Sell | 4,879 | $82.94 | $404,664.26 | -1.2% | |
| Nov 13, 2017 | NKTR Nektar Therapeutics | SVP &Chief Operating Officer | Sale+OE | 15,910 | $37.78 | $601,079.80 | -6.4% | |
| Aug 16, 2017 | NKTR Nektar Therapeutics | SVP &Chief Operating Officer | Sell | 3,177 | $19.32 | $61,379.64 | -1.4% |
Page 1Next →